Ads
related to: ibrance breast cancer drug- MONALEESA-2 Trial
Learn More About KISQALI®
See M2 Safety & Efficacy Info
- MONALEESA-3 Trial
Learn More About KISQALI®
See M3 Safety & Efficacy Info
- MONALEESA-7 Trial
Learn More About KISQALI®
See M7 Safety & Efficacy Info
- Treatment Administration
Read More About Dose Scheduling
See About Treatment Administration
- See The Patient Site
Visit The Consumer Website
Get Patient Support & More Info
- KISQALI® Video Library
View Informational Videos From
Medical Experts About KISQALI®
- MONALEESA-2 Trial
Search results
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 6 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Sanofi (SNY) Ends Development of Breast Cancer Drug, Stock Down
Zacks via Yahoo Finance· 2 years agoShares of Sanofi SNY were down 5.8% in the pre-market trading session on Aug 17, after management...
Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
Reuters via Yahoo Finance· 12 months agoNovartis breast cancer drug Kisqali cut the risk of recurrence by more than 25% in a pivotal trial...
Novartis Announces Positive Data on Breast Cancer Drug Kisqali
Zacks via Yahoo Finance· 12 months agoNovartis NVS announced positive data on the breast cancer drug Kisqali (ribociclib) from the...
What are the latest developments in breast cancer treatment? Central Mass. experts explain
Worcester Telegram & Gazette via Yahoo News· 7 months agoWORCESTER — October is Breast Cancer Awareness Month, and the rate of breast cancer incidence for...
Why more women are living with stage 4 breast cancer
The Hill via Yahoo News· 7 months agoWhen Jenny Burkholder, 51, first began feeling chest pain in 2019, she thought it was just the result of a yoga injury. “I went into chaturanga, and I...
Olema (OLMA) Up on FDA Fast Track Tag for Breast Cancer Drug
Zacks via Yahoo Finance· 2 years agoThe FDA bestows a Fast Track designation to Olema's (OLMA) novel pipeline candidate, OP-1250, for...
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said it would stop further work on breast cancer drug amcenestrant, putting...
Woman beats cancer five times to be declared free of the disease
Press Association News via AOL· 3 months agoA woman who has had cancer five times is celebrating with tough exercise challenges after being told...
What is metastatic breast cancer and why is it so misunderstood?
Yahoo Life· 2 years ago“We need to be very clear and honest about what we die from, and it’s not ‘complications from breast...
Ads
related to: ibrance breast cancer drug